The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and deadliest cancer worldwide, with an overall survival (OS) rate, all stages combined, of still <10% at 5 years. For most patients with unresectable or recurrent PDAC, few therapeutic options are available wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Marie, Haghnejad, Vincent, Schaefer, Marion, Gauchotte, Guillaume, Caron, Bénédicte, Peyrin-Biroulet, Laurent, Bronowicki, Jean-Pierre, Neuzillet, Cindy, Lopez, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870260/
https://www.ncbi.nlm.nih.gov/pubmed/35205742
http://dx.doi.org/10.3390/cancers14040995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870260/
https://www.ncbi.nlm.nih.gov/pubmed/35205742
http://dx.doi.org/10.3390/cancers14040995

Ejemplares similares